Hidden compliance risks for life sciences companies

Pharma Phorum

The life sciences history industry has some unique challenges when it comes to compliance. But if you think third party compliance risks are bad, don’t take your eye off fourth and fifth parties, says Allan Matheson.

Sharps Compliance To Present at ROTH Virtual London Conference

BioTech 365

Sharps Compliance To Present at ROTH Virtual London Conference Sharps Compliance To Present at ROTH Virtual London Conference HOUSTON, June 16, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. Nasdaq: SMED) announced today that David P. Tusa, President and Chief Executive … Continue reading → GlobeNewswire

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exploring new technology integrations to make research compliance altogether better

Forte Research Systems®

Clinical Research Technologies Compliance and Regulatory Efficient Clinical TrialsSince joining forces a year ago, Advarra and Forte have worked to ensure altogether better research, integrating Advarra’s CIRBI platform and Forte eReg.

A Message to Pharma CIOs: Optimizing Salesforce Improves Security and Compliance

Pharma Phorum

However, issues like compliance, governance and security often are. These problems tend to be the most severe in the oldest and largest Salesforce orgs, and can result in slow performance, reduced agility, sluggish adoption, misalignment and even compliance and security issues.

Sharps Compliance Announces Change to Board of Directors

BioTech 365

Sharps Compliance Announces Change to Board of Directors Sharps Compliance Announces Change to Board of Directors HOUSTON, May 24, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. NASDAQ: SMED) (“Sharps Compliance” or the “Company”), a leading full-service national provider of comprehensive … Continue reading → GlobeNewswire

Hand Hygiene Compliance Rate During the COVID-19 Pandemic

JAMA Internal Medicine

This quality improvement study assesses hand hygiene compliance rates in a hospital with an automated hand hygiene monitoring system during the COVID-19 pandemic

Experts to come together for compliance event ‘validation ready’ global labeling systems  

Pharma Phorum

Experts to come together for compliance event . This one-hour event is particularly suited to those in industry roles such as compliance, regulatory affairs and quality assurance, or anyone who needs to understand what best practice looks like in a global labeling system.

Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee

BioTech 365

Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee Fluidx’s regulatory and clinical affairs director will take the reins of the Regulatory, Compliance and Quality … Continue reading → Business Wire

ERT Improves Patient Compliance in Cardiac Studies with Home Blood Pressure Service

ERT

By offering blood pressure collection at home, we increase patient compliance and the frequency of data collection for better safety assessment.”. The post ERT Improves Patient Compliance in Cardiac Studies with Home Blood Pressure Service appeared first on ERT.

Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement

BioTech 365

Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement CHARLESTON, S.C., March 22, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a … Continue reading → GlobeNewswire

AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement

BioTech 365

AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement SAN JOSE, Calif., March 05, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., AnPac Bio,” the “Company” or “we”) (ANPC), a … Continue reading → GlobeNewswire

Politicized pandemic shaped compliance with social distancing

Scienmag

Study: Opposing messages, personal beliefs influenced behavior COLUMBUS, Ohio – Politicization of the COVID-19 pandemic had a powerful influence over adherence to social distancing guidelines in the United States and why people did, or did not, comply during the lockdown days, a new study has found. The analysis boiled down to whom study participants trusted […].

Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule

BioTech 365

Regains Compliance with Nasdaq Bid Price Rule Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule MALVERN, Pa., Ocugen Inc. 08, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene … Continue reading → GlobeNewswire

ICON Launches FIRECREST Safety Letters and Site Question Management Supporting Regulatory Compliance and Increasing Site Support

BioTech 365

Agilent Announces Enhanced Mass Spectrometry and Automation Software Solutions to Support Regulatory Compliance Guidelines

BioTech 365

Agilent Announces Enhanced Mass Spectrometry and Automation Software Solutions to Support Regulatory Compliance Guidelines Agilent Announces Enhanced Mass Spectrometry and Automation Software Solutions to Support Regulatory Compliance Guidelines SANTA CLARA, Calif.–(BUSINESS

Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

BioTech 365

Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement MONMOUTH JUNCTION, N.J., 01, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the … Continue reading → GlobeNewswire

Converting Compliance from a Cost Centre to a Critical Success Factor

Journal for Clinical Studies

Maintaining compliance can be a relentless drain on resources. Alternatively, business can make good use of the data collected for… Current features Volume 12 Issue 5

Global Managed Equipment Services (MES) & Enterprise Compliance and Quality Management (ECQM) Market (2021 to 2029) – Featuring GE Healthcare, SAP and Pilgrim Software Among Others – ResearchAndMarkets.com

BioTech 365

Global Managed Equipment Services (MES) & Enterprise Compliance and Quality Management (ECQM) Market (2021 to 2029) – Featuring GE Healthcare, SAP and Pilgrim Software Among Others – ResearchAndMarkets.com Global Managed Equipment Services (MES) & Enterprise Compliance and Quality Management (ECQM) … Continue reading → Business Wire

Scientist.com Expands Award-Winning Compliance Platform to Include International Research Consortium’s Preclinical Study Standards

BioTech 365

Improving Patient Compliance and Retention in Oncology Clinical Trials

ERT

In this blog, we explore how, by understanding patients’ preferences and meeting their expectations, sponsors can simplify their participation and improve compliance and retention to accelerate important oncology clinical trials.

SOL Global Announces Investment in Cannabis Data and Compliance Solutions Company Fyllo

BioTech 365

SOL Global Announces Investment in Cannabis Data and Compliance Solutions Company Fyllo SOL Global Announces Investment in Cannabis Data and Compliance Solutions Company Fyllo SOL Global Leads $30M Series B Round for Enterprise Technology Platform TORONTO–(BUSINESS WIRE)–SOL Global Investments Corp.

Personality traits affect shelter at home compliance

Scienmag

People low on openness, neuroticism less likely to comply without strict government policies, study says WASHINGTON – A worldwide survey conducted during the first wave of the COVID-19 pandemic found that people with certain common personality traits were less likely to shelter at home when government policies were less restrictive, according to research published by […]. Medicine & Health Behavior Political Science Public Health Science/Health/Law Social/Behavioral Science

Two Day Online Seminar: Quality and GMP Compliance for Virtual Companies – Pharmaceutical and Biologics Industries, June 10-11, 2021) – ResearchAndMarkets.com

BioTech 365

Two Day Online Seminar: Quality and GMP Compliance for Virtual Companies – Pharmaceutical and Biologics Industries, June 10-11, 2021) – ResearchAndMarkets.com Two Day Online Seminar: Quality and GMP Compliance for Virtual Companies – Pharmaceutical and Biologics Industries, June 10-11, 2021) … Continue reading → Business Wire

Informa Connect’s Compliance Congress for Specialty Products

Drug Channels

Informa Connect’s Compliance Congress for Specialty Products. June 22-24, 2021 | Virtual Event www.informaconnect.com/specialty-compliance/. Up your compliance game at this important event serving the unique sector of Specialty Products, the 7th annual Virtual Compliance Congress for Specialty Products. Exclusive Offer: Use promo code SPECIALTY10 to save 10% off* your registration fee.

Former Montana Governor Steve Bullock to Monitor Purdue’s Compliance With Voluntary Injunction

BioTech 365

Former Montana Governor Steve Bullock to Monitor Purdue’s Compliance With Voluntary Injunction Former Montana Governor Steve Bullock to Monitor Purdue’s Compliance With Voluntary Injunction STAMFORD, Conn.–(BUSINESS –(BUSINESS WIRE)–Purdue Pharma L.P. Purdue”) today announced the appointment of former Montana Governor Steve Bullock … Continue reading → Business Wire

Corizon Partner in Passaic County Earns NCCHC Reaccreditation With 100% Compliance

BioTech 365

Corizon Partner in Passaic County Earns NCCHC Reaccreditation With 100% Compliance Corizon Partner in Passaic County Earns NCCHC Reaccreditation With 100% Compliance PATERSON, N.J., 22, 2021 (GLOBE NEWSWIRE) — Corizon Health announced today the Passaic County Jail in Paterson, … Continue reading → GlobeNewswire

Courtney Barton Joins Arcutis as Chief Compliance Officer and Chief of Staff

BioTech 365

Courtney Barton Joins Arcutis as Chief Compliance Officer and Chief of Staff Courtney Barton Joins Arcutis as Chief Compliance Officer and Chief of Staff WESTLAKE VILLAGE, Calif., 18, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. Nasdaq: ARQT), a late-stage … Continue reading → GlobeNewswire

PMPRB Update: New periods for compliance with the new Guidelines

Pharma in Brief

Revised compliance period. On April 16, 2021, the PMPRB announced that it had revisited its decision on the number of reporting periods for compliance with the MLP. As a result, “the operative date for assessing compliance with the MLP will by July 1, 2022.”.

Alnylam Appoints Tolga Tanguler Chief Commercial Officer and Also Announces New CEMEA, Medical Affairs, and Compliance Leaders

BioTech 365

Alnylam Appoints Tolga Tanguler Chief Commercial Officer and Also Announces New CEMEA, Medical Affairs, and Compliance Leaders Alnylam Appoints Tolga Tanguler Chief Commercial Officer and Also Announces New CEMEA, Medical Affairs, and Compliance Leaders – Strong Commercial and Medical Team … Continue reading → Business Wire

Predictive Oncology Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement

BioTech 365

Predictive Oncology Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement Predictive Oncology Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement MINNEAPOLIS, Feb. 02, 2021 (GLOBE NEWSWIRE) — Predictive Oncology Inc. NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a … Continue reading → GlobeNewswire

Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

BioTech 365

Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule CHARLESTON, S.C., 26, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris … Continue reading → GlobeNewswire

Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

BioTech 365

Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule CHARLESTON, S.C., 26, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris … Continue reading → GlobeNewswire

Auris Medical Regains Listing Compliance with NASDAQ Minimum Bid Requirement

BioTech 365

NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it has regained compliance with … Continue reading → GlobeNewswireHamilton, Bermuda, August 20, 2020 – Auris Medical Holding Ltd.

Gilead Canada Announces Notice of Compliance for DESCOVY® (emtricitabine, tenofovir alafenamide) for HIV Pre-Exposure Prophylaxis (PrEP)

BioTech 365

CANbridge Modernizes with Veeva Vault QualityDocs to Support Global Compliance for Clinical Trials

BioTech 365

Vault QualityDocs is helping global pharma CANbridge to improve processes, reduce compliance risk, and expand clinical trials BEIJING–(BUSINESS WIRE)–Veeva Systems (NYSE: VEEV) today announced that CANbridge Pharmaceuticals Inc.,

Two Day Online Seminar: Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices – March 18-19, 2021 – ResearchAndMarkets.com

BioTech 365

Two Day Online Seminar: Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices – March 18-19, 2021 – ResearchAndMarkets.com Two Day Online Seminar: Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices – March … Continue reading → Business Wire

San Francisco based CRO, ClinPro Trials is spearheading the paradigm shift of incorporating compliance in all phases of a drug’s lifecycle from Concept to Commercialisation

BioTech 365

San Francisco based CRO, ClinPro Trials is spearheading the paradigm shift of incorporating compliance in all phases of a drug’s lifecycle from Concept to Commercialisation San Francisco based CRO, ClinPro Trials is spearheading the paradigm shift of incorporating compliance in … Continue reading → Business Wire

BioSig Deploys Vuzix M400 Smart Glasses to Offer Remote Servicing Capabilities in Compliance with COVID-19 Travel Restrictions

BioTech 365

BioSig Deploys Vuzix M400 Smart Glasses to Offer Remote Servicing Capabilities in Compliance with COVID-19 Travel Restrictions BioSig Deploys Vuzix M400 Smart Glasses to Offer Remote Servicing Capabilities in Compliance with COVID-19 Travel Restrictions Industry-leading smart glasses technology expected to … Continue reading → GlobeNewswire

Achieving GCP Compliance in Oncology Trials: The Balance between Obligation, Idealism and Realism

Journal for Clinical Studies

Good Clinical Practice (GCP) provides an internationally accepted standard to ensure subject safety and data integrity in clinical trials incorporating… Current features Volume 13 Issue 1

Lilly Announces Leadership Transitions in Manufacturing and Ethics and Compliance Organizations

The Pharma Data

Eli Lilly and Company (NYSE: LLY) today announced the upcoming retirement of two executive committee members and the naming of their successors in the company’s manufacturing operations and ethics and compliance organizations.

Genetic Technologies Regains Compliance with Nasdaq Stockholders Equity Requirement

BioTech 365

MELBOURNE, Australia, Sept. 01, 2020 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, is pleased to announce that it received notification from the Listing Qualifications Department of the Nasdaq … Continue reading → GlobeNewswire

Improve Compliance and Create Transparency with 340B Rebates (Free webinar)

Drug Channels

As regular readers know, I believe the 340B Drug Pricing Program needs to evolve into a more transparent, properly regulated program. That’s why I’m especially glad to share today’s guest post from Jeremy Docken, Founder and CEO at Kalderos.

Synthetic Biologics Announces Extension of Compliance Plan Period by NYSE American

The Pharma Data

On February 7, 2020 the NYSE American notified the Company that it accepted the Company’s plan to regain compliance before November 25, 2020 , the end of the compliance plan period. . ROCKVILLE, Md. ,